当前位置: 首页 > 期刊 > 《医药产业资讯》 > 2019年第2期
编号:13328615
利用bFGF提高直接重编程诱导成纤维细胞向心肌细胞转化效率的实验研究(4)
http://www.100md.com 2019年1月15日 《中国医药导报》 2019年第2期
     [14] Nakane T,Masumoto H,Tinney JP,et al. Impact of Cell Composition and Geometry on Human Induced Pluripotent Stem Cells-Derived Engineered Cardiac Tissue [J]. Sci Rep,2017,7:45641.

    [15] Wang X,Hodgkinson CP,Lu K,et al. Selenium Augments microRNA Directed Reprogramming of Fibroblasts to Cardiomyocytes via Nanog [J]. Sci Rep,2016,6:23017.

    [16] Zhou Y,Alimohamadi S,Wang L,et al. A Loss of Function Screen of Epigenetic Modifiers and Splicing Factors during Early Stage of Cardiac Reprogramming [J]. Stem Cells Int,2018,2018:3814747.

    [17] Engel JL,Ardehali R. Direct Cardiac Reprogramming:Progress and Promise [J]. Stem Cells Int,2018,2018:1435746.

    [18] Kojima H,Ieda M. Discovery and progress of direct cardiac reprogramming [J]. Cell Mol Life Sci,2017,74(12):2203-2215.

    [19] Van Pham P,Vu NB,Nguyen HT,et al. Significant improvement of direct reprogramming efficacy of fibroblasts into progenitor endothelial cells by ETV2 and hypoxia [J]. Stem Cell Res Ther,2016,7(1):104.

    [20] Mohamed TM,Stone NR,Berry EC,et al. Chemical Enhancement of In Vitro and In Vivo Direct Cardiac Reprogramming [J]. Circulation,2017,135(10):978-995.

    (收稿日期:2018-07-03 本文編辑:罗乔荔), 百拇医药(任杰 赵龙 宋振祥 李伟)
上一页1 2 3 4